VSee Health Inc. Reports 81% Increase in Revenue for 2024, Net Loss Widens Significantly to $57.7 Million

Reuters
2025/08/29
<a href="https://laohu8.com/S/VSEE">VSee Health</a> Inc. Reports 81% Increase in Revenue for 2024, Net Loss Widens Significantly to $57.7 Million

VSee Health Inc. reported significant financial results for the fiscal year ending December 31, 2024. The company achieved revenues of $10.4 million, representing an 81% increase compared to $5.8 million in 2023. Despite this growth in revenue, VSee Health recorded a net loss of $57.7 million, a substantial increase from the net loss of $3.7 million in the prior year. The gross margin for VSee Health rose to $7.2 million, up from $3.8 million the previous year, marking an 87% improvement. Operating expenses soared to $69.3 million from $5.7 million, a significant rise that impacted the company's bottom line. In terms of other income and expenses, VSee Health reported a net gain of $2.8 million compared to a slight loss of $13,375 in the prior year. The company also noted an income tax benefit of $1.6 million, contrasting with a provision of $1.8 million the year before. Business operations continue to focus on generating revenue through subscription services to its software platform via its subsidiary, VSee Lab. The company has adjusted its financial statements, reflecting restatement adjustments in its financial analysis.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VSee Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-011813), on August 28, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10